Dulera (Merck Sharp & Dohme Corp.)


Welcome to the PulseAid listing for the Dulera drug offered from Merck Sharp & Dohme Corp.. This Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Corticosteroid Hormone Receptor Agonists [MoA],Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Merck Sharp & Dohme Corp.
NON-PROPRIETARY NAME: mometasone furoate and formoterol fumarate dihydrate
SUBSTANCE NAME: MOMETASONE FUROATE; FORMOTEROL FUMARATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Corticosteroid Hormone Receptor Agonists [MoA],Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC]
ROUTE: RESPIRATORY (INHALATION)
DOSAGE FORM: AEROSOL
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2010-06-22
END MARKETING DATE: 0000-00-00


Dulera HUMAN PRESCRIPTION DRUG Details:

Item DescriptionDulera from Merck Sharp & Dohme Corp.
LABELER NAME: Merck Sharp & Dohme Corp.
DEA SCHEDULE:
ACTIVE STRENGTH: 200; 5(ug/1; ug/1)
START MARKETING DATE: 2010-06-22
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0085-4610_523ae931-7b52-485c-bfd3-390686b2a4d0
PRODUCT NDC: 0085-4610
APPLICATION NUMBER: NDA022518

Other MOMETASONE FUROATE; FORMOTEROL FUMARATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Merck Sharp & Dohme Corp.Dulera